National Research Corporation (NRCIB) - NASDAQ
  • Nov. 4, 2013, 9:54 AM
    • The B-class stock of National Research Corporation (NRCIB +5.9%) continues a big move following SA Pro's Christopher Owens on Wednesday making the case for their massive undervaluation.
    • Mr. Market has seriously misjudged the potential for National Research to be acquired (which wouldn't be good for the B-class shares), says Owens. Instead, he argues, the new structure was undertaken to allow the CEO to monetize some holdings while maintaining voting control, and for the creation of a non-dilutive acquisition currency (the A-shares).
    • If Owens is right, the B-shares - with voting superiority and entitled to 6x the dividend of the A-class - should trade at 6x the level of the A-shares, making them a potential 3-bagger with limited downside.
    | Nov. 4, 2013, 9:54 AM
  • Aug. 23, 2013, 12:46 PM
    | Aug. 23, 2013, 12:46 PM
Company Description
National Research Corp. provides analytics and insights that facilitate patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its solutions support the improvement of business and clinical outcomes, while facilitating... More
Sector: Services
Industry: Research Services
Country: United States